Cargando…

Use of a non-medicated plaster in chronic lumbar back pain: a randomized controlled trial

BACKGROUND AND AIM: The latest technology on far infrared radiations reflects the radiations emitted by the human body and induces an antalgic and anti-inflammatory effect without active ingredients. Our primary aim was to assess pain level modifications throughout the treatment period with two diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricci, Matteo, Mulone, Alessio, Elena, Nicholas, Vecchini, Eugenio, Valentini, Roberto, Gelmini, Margherita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534234/
https://www.ncbi.nlm.nih.gov/pubmed/36043965
http://dx.doi.org/10.23750/abm.v93i4.12931
_version_ 1784802498025881600
author Ricci, Matteo
Mulone, Alessio
Elena, Nicholas
Vecchini, Eugenio
Valentini, Roberto
Gelmini, Margherita
author_facet Ricci, Matteo
Mulone, Alessio
Elena, Nicholas
Vecchini, Eugenio
Valentini, Roberto
Gelmini, Margherita
author_sort Ricci, Matteo
collection PubMed
description BACKGROUND AND AIM: The latest technology on far infrared radiations reflects the radiations emitted by the human body and induces an antalgic and anti-inflammatory effect without active ingredients. Our primary aim was to assess pain level modifications throughout the treatment period with two different types of patches, compared to a placebo. As secondary aims, we focused on addressing patients’ quality of life and range of motion changes with each patch. METHODS: We assessed 54 patients with chronic lumbar back pain treated with FIT Therapy (far infrared technology) patch. Three different types of FIT Therapy patches (F4, F3, and placebo) were used according to the different power of action and patients allocated in a randomized fashion into the 3 arms of the study. Every single patient was assessed during the study using the VAS pain scale, the Roland Morris Disability Questionnaire for quality of life, and ROM for a total of 14 days. RESULTS: Only the F4 patch group significantly reduced pain level at T14 compared to the placebo group (p<0.05). Meanwhile, F3 showed only a non-significant decrease compared to placebo (p=0.254). In terms of lifestyle improvements, both F3 and F4 recorded a decrease on the RMDQ of 4 and 6 points, respectively. CONCLUSIONS: Currently, we still need further studies with longer follow-up to consider the FIT Therapy patches F4 a valid alternative as a “non-medicated pain relief”, but it proved to have a role in alleviating painful symptoms and improving function in chronic lumbar back pain without adverse events. (www.actabiomedica.it)
format Online
Article
Text
id pubmed-9534234
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-95342342022-10-18 Use of a non-medicated plaster in chronic lumbar back pain: a randomized controlled trial Ricci, Matteo Mulone, Alessio Elena, Nicholas Vecchini, Eugenio Valentini, Roberto Gelmini, Margherita Acta Biomed Original Article BACKGROUND AND AIM: The latest technology on far infrared radiations reflects the radiations emitted by the human body and induces an antalgic and anti-inflammatory effect without active ingredients. Our primary aim was to assess pain level modifications throughout the treatment period with two different types of patches, compared to a placebo. As secondary aims, we focused on addressing patients’ quality of life and range of motion changes with each patch. METHODS: We assessed 54 patients with chronic lumbar back pain treated with FIT Therapy (far infrared technology) patch. Three different types of FIT Therapy patches (F4, F3, and placebo) were used according to the different power of action and patients allocated in a randomized fashion into the 3 arms of the study. Every single patient was assessed during the study using the VAS pain scale, the Roland Morris Disability Questionnaire for quality of life, and ROM for a total of 14 days. RESULTS: Only the F4 patch group significantly reduced pain level at T14 compared to the placebo group (p<0.05). Meanwhile, F3 showed only a non-significant decrease compared to placebo (p=0.254). In terms of lifestyle improvements, both F3 and F4 recorded a decrease on the RMDQ of 4 and 6 points, respectively. CONCLUSIONS: Currently, we still need further studies with longer follow-up to consider the FIT Therapy patches F4 a valid alternative as a “non-medicated pain relief”, but it proved to have a role in alleviating painful symptoms and improving function in chronic lumbar back pain without adverse events. (www.actabiomedica.it) Mattioli 1885 2022 2022-08-31 /pmc/articles/PMC9534234/ /pubmed/36043965 http://dx.doi.org/10.23750/abm.v93i4.12931 Text en Copyright: © 2022 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article
Ricci, Matteo
Mulone, Alessio
Elena, Nicholas
Vecchini, Eugenio
Valentini, Roberto
Gelmini, Margherita
Use of a non-medicated plaster in chronic lumbar back pain: a randomized controlled trial
title Use of a non-medicated plaster in chronic lumbar back pain: a randomized controlled trial
title_full Use of a non-medicated plaster in chronic lumbar back pain: a randomized controlled trial
title_fullStr Use of a non-medicated plaster in chronic lumbar back pain: a randomized controlled trial
title_full_unstemmed Use of a non-medicated plaster in chronic lumbar back pain: a randomized controlled trial
title_short Use of a non-medicated plaster in chronic lumbar back pain: a randomized controlled trial
title_sort use of a non-medicated plaster in chronic lumbar back pain: a randomized controlled trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534234/
https://www.ncbi.nlm.nih.gov/pubmed/36043965
http://dx.doi.org/10.23750/abm.v93i4.12931
work_keys_str_mv AT riccimatteo useofanonmedicatedplasterinchroniclumbarbackpainarandomizedcontrolledtrial
AT mulonealessio useofanonmedicatedplasterinchroniclumbarbackpainarandomizedcontrolledtrial
AT elenanicholas useofanonmedicatedplasterinchroniclumbarbackpainarandomizedcontrolledtrial
AT vecchinieugenio useofanonmedicatedplasterinchroniclumbarbackpainarandomizedcontrolledtrial
AT valentiniroberto useofanonmedicatedplasterinchroniclumbarbackpainarandomizedcontrolledtrial
AT gelminimargherita useofanonmedicatedplasterinchroniclumbarbackpainarandomizedcontrolledtrial